C2N Diagnostics is Drug Discovery in United States that focus on platform quantifies business. Founded in 2007. They cover business area such as developer, provider, clinical diagnostic, therapeutic, brain disorder, biomarker, neurodegenerative condition, the-art, liquid chromatographic separation and mass spectrometry quantification technology, doctor, neurocognitive disorder.
2007
( 17 years old in 2024 )
Platform Quantifies
-
Center for Emerging Technologies
20 South Sarah Street
Saint Louis, MO 63108
United States
Private
developerproviderclinical diagnostictherapeuticbrain disorderbiomarkerneurodegenerative conditionthe-artliquid chromatographic separation and mass spectrometry quantification technologydoctorneurocognitive disorder
* We use standard office opening hours in near C2N Diagnostics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
C2N Diagnostics is Drug Discovery business from United States that founded in 2007 (17 years old in 2024), C2N Diagnostics business is focusing on Platform Quantifies.
C2N Diagnostics headquarter office and corporate office address is located in Center for Emerging Technologies 20 South Sarah Street Saint Louis, MO 63108 United States.
C2N Diagnostics was founded in United States.
In 2024, C2N Diagnostics is currently focus on platform quantifies sector.
Above is snippet of Google Trends for "platform quantifies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with C2N Diagnostics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
